Home
Diseases
Hematological Neoplasms
Solid tumors
Cancer prone diseases
Case reports
Genes
Gene Reviews
Gene fusions
Education
Deep insights
Educational items 🇬🇧 🇪🇸 🇫🇷 🇩🇪 🇮🇹 🇨🇳
Meetings
Meetings & Events
Submit your event
Donate
News
New Atlas 2.0
Complete human genomed sequenced
HGNC Gene Fusions Nomenclature
Recent Contents
Submit
ARTICLE CONTENTS
To the top
Other actions (beta)
Download as PDF
Diamond-Blackfan anemia (DBA)
2007-02-01
Hanna T. Gazda
 
Affiliation
Harvard Medical School, Childrens Hospital Boston, 300 Longwood Ave., Boston, MA 02115, USA
Identity
Name
Diamond-Blackfan anemia (DBA)
Inheritance
Genetic heterogeneity; majority of cases autosomal dominant, occasionally with variable expression (incomplete dominance) manifesting as mild anemia or only macrocytosis and\/or elevated erythrocyte adenosine deaminase activity (eADA) in transmitting parent or in siblings; some cases apparently autosomal recessive, not linked to 19q
Omim
105650 , 205900 , 300946 , 606129 , 606164 , 610629 , 612527 , 612528 , 612561 , 612562 , 612563 , 613308 , 613309 , 614900 , 615550 , 615909
Mesh
D029503
Orphanet
124 Blackfan-Diamond anemia
Umls
C1260899
Clinics
Note
Chronic constitutional aregenerative anemia with absent or decreased red cell precursors in bone marrow.
Macrocytosis, elevated fetal hemoglobin and increased eADA.
Physical abnormalities in about 40% of DBA cases including craniofacial and thumb abnormalities, atrial or ventrucular septal defects, short stature, mild retardation, etc.
Hematologic malignancy : in 2.5% of all reported cases of DBA; primarily
ANLL
with no FAB preference but also ALL,
Hodgkins disease
.
Solid tumors include carcinoma of liver, stomach, osteogenic sarcoma.
Age of malignancy onset from 2 to 43 years.
Disease-related and treatment-related factors, i.e., allosensitization and iron overload, contribute to malignancy.
Treatment
Corticosteroids, transfusion, bone marrow transplant.
Evolution
Some patients enter remission, with or without corticosteroid therapy.
Prognosis
Median survival: 38 years
Genes involved and Proteins
Description
Ribosomal protein S19; ribosomal proteins are a major component of cellular proteins. In general their function(s), aside from being part of the ribosome, are unknown. However, RPS19 protein was shown to be essential for 18S rRNA maturation and 40S subunit synthesis. Haplo-insufficiency of the protein encoded by the mutated gene is a likely mechanism underlying the pathogenesis of DBA.
Germinal
62 different heterozygous mutations in RPS19 were identified and reported in 113 of the 457 (about 25%) DBA probands. They were non-sense, frameshift, splice site and missense mutations. Several patients had disease-associated chromosomal abnormalities in DBA region, including t(X;19), t(8;19), and 19q microdeletions.
Description
ribosomal protein S24
Germinal
Three heterozygous mutations in RPS24 (two nonsense and one splice site mutations causing premature termination codons and skipped exon, respectively) were identified among 185 RPS19-negative DBA probands (about 2%).
Article Bibliography
Pubmed ID
Last Year
Title
Authors
17053056
2007
Impaired ribosome biogenesis in Diamond-Blackfan anemia.
Choesmel V et al
17082006
2006
Translational efficiency in patients with Diamond-Blackfan anemia.
Cmejlova J et al
12393682
2003
Ribosomal protein S19 expression during erythroid differentiation.
Da Costa L et al
9988267
1999
The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia.
Draptchinskaia N et al
15755903
2005
An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray.
Ebert BL et al
16537118
2006
High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries.
Faivre L et al
16990592
2007
Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits.
Flygare J et al
17164339
2007
Diamond-Blackfan anemia: erythropoiesis lost in translation.
Flygare J et al
17186470
2006
Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia.
Gazda HT et al
16741228
2006
Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia.
Gazda HT et al
15384984
2004
RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations.
Gazda HT et al
9792865
1998
Identification of microdeletions spanning the Diamond-Blackfan anemia locus on 19q13 and evidence for genetic heterogeneity.
Gustavsson P et al
8606629
1996
Diamond-Blackfan anemia. Natural history and sequelae of treatment.
Janov AJ et al
15238419
2005
Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect.
Ohene-Abuakwa Y et al
15059149
2004
Diamond Blackfan anaemia in the UK: clinical and genetic heterogeneity.
Orfali KA et al
17151020
2007
Analysis of the ribosomal protein S19 interactome.
Orrù S et al
11563775
2001
The Diamond Blackfan Anemia Registry: tool for investigating the epidemiology and biology of Diamond-Blackfan anemia.
Vlachos A et al
10590074
1999
Mutations in ribosomal protein S19 gene and diamond blackfan anemia: wide variations in phenotypic expression.
Willig TN et al
8625135
1995
Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.
van Dijken PJ et al
External Links
GARD
ERN GENTURIS
OMIM
ORPHANET
MeSH
Generate PDF
×
Please, confirm that you want to generate a PDF file of this page.
This may take some seconds once process has started. Then it will be opened automatically.
Wait a moment, we are generating the document...
Aditional Info
×
Loading, wait...